Target type: biologicalprocess
Any process that activates or increases the frequency, rate, or extent of toll-like receptor 2 signaling pathway. [GOC:add, PMID:16551253, PMID:17328678]
Positive regulation of toll-like receptor 2 (TLR2) signaling pathway is a complex process that involves the activation of multiple signaling cascades, leading to the production of pro-inflammatory cytokines and chemokines. This pathway is essential for the innate immune response to a variety of pathogens, including bacteria, fungi, and parasites.
**1. TLR2 Recognition:** The process begins with the recognition of pathogen-associated molecular patterns (PAMPs) by TLR2. TLR2 is a transmembrane protein expressed on the surface of immune cells, such as macrophages, dendritic cells, and neutrophils. It recognizes a wide range of PAMPs, including lipoproteins, peptidoglycans, and zymosan, which are found in the cell walls of bacteria, fungi, and parasites.
**2. Receptor Dimerization:** Upon binding to its ligand, TLR2 dimerizes with another TLR2 molecule or with TLR1 or TLR6. This dimerization is crucial for the activation of downstream signaling pathways.
**3. Adaptor Protein Recruitment:** The dimerized TLR2 complex recruits adaptor proteins, such as myeloid differentiation primary response gene 88 (MyD88). MyD88 acts as a scaffold protein that brings together other signaling molecules.
**4. IRAK Activation:** MyD88 recruits IL-1 receptor-associated kinases (IRAKs), such as IRAK1 and IRAK4. IRAK4 phosphorylates IRAK1, leading to its activation.
**5. TRAF6 Activation:** Activated IRAK1 interacts with TNF receptor-associated factor 6 (TRAF6). TRAF6 is a ubiquitin ligase that plays a crucial role in the activation of downstream signaling pathways.
**6. MAPK and NF-κB Pathways:** TRAF6 activates the mitogen-activated protein kinase (MAPK) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathways.
**7. Cytokine Production:** The activation of MAPK and NF-κB pathways leads to the production of pro-inflammatory cytokines, such as TNF-α, IL-6, IL-1β, and chemokines. These cytokines recruit immune cells to the site of infection and promote inflammation.
**8. Immune Cell Activation:** The cytokines produced by TLR2 signaling pathway activate other immune cells, such as T cells and B cells, leading to a coordinated immune response.
**9. Negative Regulation:** To prevent excessive inflammation and damage to the host, the TLR2 signaling pathway is tightly regulated by negative feedback mechanisms. These mechanisms include the recruitment of inhibitory proteins, such as IRAK-M and Tollip, which inhibit the activation of downstream signaling pathways.
In summary, positive regulation of TLR2 signaling pathway is a complex process involving multiple steps that lead to the activation of downstream signaling pathways, cytokine production, and immune cell activation. This pathway is essential for the innate immune response to a variety of pathogens and plays a crucial role in host defense.'
"
Protein | Definition | Taxonomy |
---|---|---|
Proteinase-activated receptor 2 | A proteinase-activated receptor 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P55085] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
triptolide | diterpenoid; epoxide; gamma-lactam; organic heteroheptacyclic compound | antispermatogenic agent; plant metabolite | |
seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide | seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide: a proteinase-activated receptor-2-activating peptide; SL-NH2 is NOT Ser-Leu-NH2 here | ||
2-furoyl-ligrlo-amide | 2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist | ||
AZ3451 | benzimidazoles; benzodioxoles; nitrile; organobromine compound; secondary carboxamide | anti-inflammatory agent; autophagy inducer; PAR2 negative allosteric modulator |